Adverse effects

被引：0

作者：

不详

机构：

来源：

AUSTRALIAN PRESCRIBER | 2006年 / 29卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：133 / 133

页数：1

共 9 条

[1] Therapeutic monoclonal antibodies [J].

Breedveld, FC .

LANCET, 2000, 355 (9205) :735-740

[2] Immunosuppressive drugs for kidney transplantation [J].

Halloran, PF .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) :2715-2729

[3]

McColl G, 2004, AUST PRESCR, V27, P43

[4] Immunosuppressants - mechanisms of action and monitoring [J].

Pillans, Peter .

AUSTRALIAN PRESCRIBER, 2006, 29 (04) :99-101

[5] Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial [J].

Reich, K ;

Nestle, FO ;

Papp, K ;

Ortonne, JP ;

Evans, R ;

Guzzo, C ;

Li, S ;

Dooley, LT ;

Griffiths, CEM .

LANCET, 2005, 366 (9494) :1367-1374

[6] Natalizumab induction and maintenance therapy for Crohn's disease [J].

Sandborn, WJ ;

Colombel, JF ;

Enns, R ;

Feagan, BG ;

Hanauer, SB ;

Lawrance, IC ;

Panaccione, R ;

Sanders, M ;

Schreiber, S ;

Targan, S ;

van Deventer, S ;

Goldblum, R ;

Despain, D ;

Hogge, GS ;

Rutgeerts, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (18) :1912-1925

[7] Advances in psoriasis treatment [J].

Schön, MP .

LANCET, 2005, 366 (9494) :1333-1335

[8] Immunosuppressants - clinical applications [J].

Trevillian, Paul .

AUSTRALIAN PRESCRIBER, 2006, 29 (04) :102-108

[9]

Ward R., 2003, AUST PRESCR, V26, P141

← 1 →